on Friday, October 1, 2010
Gerald A. Soff has been appointed Chief of the Hematology Service within the Department of Medicine’s Division of Hematologic Oncology.
Gerald A. Soff has been appointed Chief of the Hematology Service within the Department of Medicine’s Division of Hematologic Oncology. Under Dr. Soff’s leadership, the Hematology Service will focus on the management and study of non-neoplastic hematologic disorders, including thrombosis, blood coagulation, and disorders of red cells and platelets. This will include a particular focus on the hematologic disorders that occur in cancer patients.
Dr. Soff is a hematologist who specializes in benign hematologic disorders. He joined Memorial Sloan Kettering Cancer Center in 2009 as Director of the Benign Hematology Program. He has extensive experience in the diagnosis and management of thrombotic diseases as well as hemorrhagic disorders, an expertise that is of particular benefit to those patients with cancer who are at risk for both thrombosis and bleeding. His research involves studies of the interaction of the coagulation system and cancer. He is also actively involved in training medical students and residents in hematology.
After receiving his MD degree in 1981 from The Johns Hopkins School of Medicine, Dr. Soff did his residency training at the Medical College of Virginia and subsequently completed a hematology/oncology fellowship at Beth Israel Deaconess Medical Center, in Boston. Prior to joining Memorial Sloan Kettering, Dr. Soff had been Chief of the Division of Hematology/Oncology at SUNY Downstate Medical Center. He is board certified in internal medicine and hematology.
Dr. Soff succeeds Stephen D. Nimer, who has served with distinction as Chief of the Hematology Service since its inception nearly 20 years ago. Dr. Nimer, incumbent of the Alfred P. Sloan Chair, is a noted expert in hematologic cancers and autologous bone marrow transplantation. He now serves as Vice Chair for Faculty Development in the Department of Medicine, and is a Member of the Sloan Kettering Institute as well as an attending physician on the Leukemia Service.